North America Interventional Oncology Market Overview:
The North America
Interventional Oncology Market to reach USD 1,150.5 million by 2025 from
USD 705.0 million in 2018, growing at a CAGR of 7.37% during the forecast
period 2025.
Interventional oncology is a branch of medical science that
deals with minimally invasive medical procedures performed by interventional
radiologists for the diagnosis, treatment and palliation of different types of
cancer.
Browse
details of 140 number of pages research report developed on North
America Interventional Oncology Market Research Report @ https://www.researchcosmos.com/reports/north-america-interventional-oncology-market/815710683
Drivers, Challenges
and Opportunities of North America
Interventional Oncology Market:
The growing demand for minimally invasive therapies has been
the propelling factor for the North American interventional oncology market.
The ability of these techniques to treat cancer cells better than alternative
treatments, such as radiotherapy, surgery and routine chemotherapy, has allowed
this technique to gain popularity through the region. In addition, health
professionals and patients are progressively opting for minimally invasive
procedures in the area of interventional oncology because of the advantages
such as shorter hospital stay, minimal risk of infection, less complications,
less pain and faster recovery time compared to conventional surgeries. These
benefits of using minimally invasive procedures will further stimulate the
growth of the interventional oncology market in North America.
Interventional oncology is used to treat primary or
metastatic cancer, such as liver cancer, kidney cancer, lung cancer, prostate
cancer, breast cancer and pancreatic cancer, which is also another supporting
factor for the local market. Due to its minimally invasive nature, the required
recovery time is minimal along with the hospital stay. Some of the popular
procedures in the business are pain palliation, intra-arterial therapies,
ablative therapies and neoadjuvant procedures.
Ask Free
Sample of the Report @ https://www.researchcosmos.com/request/north-america-interventional-oncology-market/815710683
Geographic
Segmentation:
North America is expected to be an important part of the
interventional oncology market due to its large population affected by chronic
cancer, such as hepatocellular carcinoma, lung cancer, kidney cancer and
metastatic colorectal cancer. In addition, the significant adoption of
minimally invasive surgeries for effective cancer management, a
well-established health infrastructure and rapid adoption of state-of-the-art products
is boosting the market, which will result in more acceptance among the
population over the forecast period.
Some of the prominent
players in the North America Interventional Oncology Market are: Boston Scientific Corporation, Medtronic plc,
Terumo Corporation, BTG plc, AngioDynamics, Inc., Ethicon, Inc. (Johnson &
Johnson), Merit Medical Systems, Inc. and Sirtex Medical Limited, Siemens
Healthineers, Eckert & Ziegler BEBIG, Varian Medical Systems, Inc. and
HealthTronics, Inc etc.
For any queries, inquire more @ https://www.researchcosmos.com/inquire/north-america-interventional-oncology-market/815710683
About
Us:
Research Cosmos
is a provider of standard and customized Industry research, business
intelligence and consulting services across more than 100 domains in different
industries of the world. We host the trending Industry reports of the world’s
top-notch publishing companies, offering services to a wide range of customers
from students to fortune 500 companies and discloses the hidden opportunities
in every leading industry of the world.
Contact:
Kevin Stewart
kevin@researchcosmos.com
Global Sales Manager
Research Cosmos
www.researchcosmos.com
+1 888 709 8757
https://marketreportsweb.com/
https://acutemarketinsights.com/
kevin@researchcosmos.com
Global Sales Manager
Research Cosmos
www.researchcosmos.com
+1 888 709 8757
https://marketreportsweb.com/
https://acutemarketinsights.com/
No comments:
Post a Comment